🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Assessment of effectiveness, safety and local immune activation of Oncolyti...
Status
Completed
Location
Fudan University Shanghai Cancer Center
Start Date
2021-03-05
Trial ID
NCT04771676
Treatments Being Tested
Primary Objective: • To evaluate the safety and tolerability of cAd3-EBO-S...
Status
Completed
Location
Oklahoma Blood Institute (OBI)
Start Date
2021-01-06
Trial ID
NCT04723602
Treatments Being Tested
Indication: Hepatocellular carcinoma (HCC) patients at Barcelona Clinic Liv...
Status
Not Yet Recruiting
Location
The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital
Start Date
2024-11
Trial ID
NCT06685354
Treatments Being Tested
This prospective, single-arm study was aimed to evaluate the efficacy of re...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-03-30
Trial ID
NCT06253598
Treatments Being Tested
The purpose of the study is to assess: 1 safety and tolerability of adenovi...
Status
Completed
Location
Multiple Locations
Start Date
2016-09
Trial ID
NCT02919306
Treatments Being Tested
This is a multicenter, open-label, partially radomized, parallel-controlled...
Status
Completed
Location
Jiangsu Provincial Center for Diseases Control and Prevention
Start Date
2022-01-22
Trial ID
NCT05204589
Treatments Being Tested
This study aims to evaluate the safety and effectiveness of a combination t...
Status
Not Yet Recruiting
Location
Chongqing University Cancer Hospital
Start Date
2026-05-01
Trial ID
NCT07543848
Treatments Being Tested
Sorafenib, as a first-line treatment for patients with advanced HCC, can si...
Status
Unknown
Location
Shaanxi Provincial People's Hospital
Start Date
2021-12-28
Trial ID
NCT05113290
Treatments Being Tested
This is a single center, open, dose-escalation phase 1 clinical trial. This...
Status
Completed
Location
First affiliated hospital of Zhejiang University
Start Date
2015-03
Trial ID
NCT02401373
Treatments Being Tested
This is a prospective, open label, single center clinical study on the use ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-02-01
Trial ID
NCT07356791
Treatments Being Tested